Sort
11,323 grants matching “glioblastoma”
SapC-DOPS nanovesicles for Treating Glioblastoma Multiforme
$670,367Kevin Xu · Bexion Pharmaceuticals, Inc. · R44 · FY2010 · CA
Brain Tumors - Immunological and Biological Studies
$670,357Darell D Bigner · Duke University · R37 · FY2008 · CA
Integrated ligand and target discovery by chemical proteomics for glioblastoma treatment.
$670,026Paul S Mischel · Stanford University · R01 · FY2025 · CA
Integrating circulating tumor DNA assay and protein-based MRI to accurately monitor glioma therapy
$669,307Shanshan Jiang · Johns Hopkins University · R01 · FY2025 · CA
Developing macrophage reprogramming mRNA nanocarriers for initial clinical testing
$669,177Matthias Stephan · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
(PQD3) Mechanisms of prolonged initial disease-free survival in glioblastoma
$669,147Jann N Sarkaria · Mayo Clinic Rochester · R01 · FY2014 · CA
Phase IIA Trial of Dichloroacetate for Glioblastoma Multiforme, IND137007, 09172019
$669,027Peter W. Stacpoole · University Of Florida · R01 · FY2024 · FD
Synthetic lethalities to cell cycle disruption in glioma
$668,921Rameen Beroukhim · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Quantitative Image Informatics for Cancer Research (QIICR)
$668,889Ron Kikinis · Brigham And Women'S Hospital · U24 · FY2016 · CA
Quantitative Image Informatics for Cancer Research (QIICR)
$668,865Ron Kikinis · Brigham And Women'S Hospital · U24 · FY2017 · CA
Theranostics for Pediatric Brain Cancer
$668,562Heike Elizabeth Daldrup-Link · Stanford University · R01 · FY2022 · HD
Project 1: Targeting cytomegalovirus antigens in glioblastoma with regulatory T cell depletion
$668,450John H Sampson · Duke University · P01 · FY2019 · CA
Understanding and manipulating programmed cell death (PCD) pathways to facilitate lymphoid tumor killing by CAR T cells
$667,996Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2024 · CA
Role of Neurotrophins in the Development of the Mammalian Nervous System
$667,915Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Antibodies, B cells and resistance to human cryptococcosis
$667,846Liise-Anne Pirofski · Albert Einstein College Of Medicine · R01 · FY2020 · AI
Advancing treatment outcomes in malignant glioma by integrating immunotherapy and standard of care using genetically engineered mice that recapitulate molecular feature of human glioma
$667,694Alain Charest · Beth Israel Deaconess Medical Center · R01 · FY2018 · CA
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
$667,615Kristin R Swanson · Mayo Clinic Arizona · U01 · FY2021 · CA
The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis
$667,359William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
Targeting Immunosuppression Pathways to Enhance Brain Tumor Immunotherapy
$667,257John H Sampson · Duke University · P01 · FY2014 · CA
Development and validation of an autologous mouse model for the study of immune interactions with glioblastoma
$667,171Zev Ari Binder · University Of Pennsylvania · R37 · FY2025 · CA
Transport Processes and Nervous System Function
$667,133Peter J. Basser · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
Dosimetry, Physics & Modeling Core
$667,065Charles Limoli · University Of California-Irvine · P01 · FY2022 · CA
Integrated ligand and target discovery by chemical proteomics for glioblastoma treatment.
$666,928Paul S Mischel · Stanford University · R01 · FY2023 · CA
Methylation and mutations in RB1 and variants of synthetic folic acid metabolism
$666,923Manuela A Orjuela · Columbia University Health Sciences · R01 · FY2015 · CA
Mapping Immune Contexture and Crosstalk with Tumor Cells At GBM Margin
$666,772Hongyan Jenny Zou · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · NS